Please report any queries concerning the funding data grouped in the
sections named
"Externally Awarded"
or
"Internally Disbursed"
(shown on the profile page) to your Research Finance Administrator.
Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php
by entering your department
Please report any queries concerning the student data shown on the
profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
› More
search options
Mr Asllan Gjinovci
Appointment
- Research Associate
- Div of Infection & Immunity
- Faculty of Medical Sciences
Research Themes
See
More
See
Less
Research Summary
Invention
Asllan Gjinovci at the University of Geneva has significantly improved the technology of pancreatic perfusion to study drug effects on endocrine and exocrine pancreas secretion.
Organs are perfused with perfusion buffer and the molecules of interest. Flow rate is kept constant at 5 ml/min (rat) or 1.5 ml/min (mouse). Pancreatic effluent and pancreatic juice are collected and analyzed by standard method.
Applications
- Perfusion of pancreas allows the testing of molecules on endocrine (insulin, glucagon, somatostatin) and exocrine (amylase, chymotrypsin) pancreatic secretion
- Drug screening, preclinical studies, ADME/TOX
- Therapeutic areas include: diabetes, obesity, metabolic disease
Compared to other techniques, the Gjinovci method displays the following advantages:
- Increase analysis time: 3 to 4 hours instead of 20 minutes
- Allows the testing of higher number of drugs
- Limits the quantity of animals used
- permits the possibility of increased experimentation time
- Absence of edema due to specific surgery
- Possibility of double perfusion: pancreas and kidney
- Applicable to genetically modified animals and different species (rats, mice)
- Applicable to other organs such as liver, kidney and spleen
